Fractional shares
Get dividend payments
Gilead Sciences Inc (GILD) is a publicly traded drug manufacturers - general business based in the US which employs around 18,000 staff. Gilead Sciences is listed on the NASDAQ and traded in US dollars. Its current price of $92.34 is 10.2% up on its price a month ago ($83.79).
Both exchange rates and share prices fluctuate in real time, so the costs estimated here should be considered as a guide only. They don't factor in spreads, which can be hard to pin down. Always refer to the platform itself for availability and pricing.
Quantity of shares
Platform | Finder Score | Account fee | Min. initial deposit | Trade cost | Link |
---|---|---|---|---|---|
9
Excellent
|
£0 | $100 | £877.04 |
Go to siteCapital at risk
|
|
9.1
Excellent
|
£0 | £1 | £879.13 |
Go to siteCapital at risk
|
|
9
Excellent
|
£0 | £0 | £874.86 |
Go to siteCapital at risk
|
|
9
Excellent
|
£0 | £0 | £874.86 |
Go to siteCapital at risk
|
|
8.5
Great
|
£0 (0.45% for funds) | £1 | £891.16 |
Go to siteCapital at risk
|
|
9.3
Excellent
|
0% - 0.25% | £100 | N/A |
Go to siteCapital at risk
|
Full comparison of share dealing platforms
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Buying shares in just one company is generally considered a riskier bet than investing in a range of investments - AKA a "diversified portfolio". Experts generally recommend holding a mix of investments in specific assets and funds. Funds are ready-made portfolios of multiple companies' shares (potentially including Gilead Sciences), and the idea is that drops in the value of one constituent company's share price might be offset by rises in others.
Gilead Sciences is a major part of the NASDAQ, so it's included in many global funds and investment trusts, as well as tracker-style exchange traded funds (ETFs).
ETF | Icon | 5-year performance (to August 2024) | 1-year performance (to August 2024) | Link to invest |
---|---|---|---|---|
Invesco S&P 500 (SPXP) | 94.07% | 22.23% | Invest with XTBCapital at risk | |
Xtrackers S&P 500 Swap (XSPX) | 93.77% | 22.24% | Invest with XTBCapital at risk | |
iShares Core S&P 500 (CSP1) | 91.84% | 21.98% | Invest with XTBCapital at risk | |
HSBC S&P 500 (HSPX) | 80.38% | 20.63% | Invest with XTBCapital at risk | |
Vanguard S&P 500 (VUSA) | 79.29% | 20.60% | Invest with XTBCapital at risk | |
SPDR S&P 500 ETF (SPX5) | 79.17% | 20.61% | Invest with XTBCapital at risk |
Review technicals and fundamentals to help you determine if now's a good time for you to invest.
View Gilead Sciences's price performance, share price volatility, historical data and technicals.
Historical closes compared with the last close of $92.34
1 week (2024-12-04) | 5.70% |
---|---|
1 month (2024-11-11) | 10.20% |
3 months (2024-09-11) | 21.03% |
6 months (2024-06-11) | 44.22% |
1 year (2023-12-11) | 22.69% |
2 years (2022-12-11) | 43.41% |
3 years (2021-12-11) | 54.52% |
5 years (2019-12-11) | 79.04% |
The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Ever wondered how to buy shares in Canopy Growth? We explain how and compare a range of providers that can give you access to many brands, including Canopy Growth.
Ever wondered how to buy shares in Green Thumb Industries? We explain how and compare a range of providers that can give you access to many brands, including Green Thumb Industries.
Ever wondered how to buy shares in Curaleaf Holdings? We explain how and compare a range of providers that can give you access to many brands, including Curaleaf Holdings.
Ever wondered how to buy shares in Genesis Healthcare? We explain how and compare a range of providers that can give you access to many brands, including Genesis Healthcare.
Ever wondered how to buy shares in Allergy Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including Allergy Therapeutics.
Ever wondered how to buy shares in 4D pharma? We explain how and compare a range of providers that can give you access to many brands, including 4D pharma.
Ever wondered how to buy shares in Aurora Cannabis? We explain how and compare a range of providers that can give you access to many brands, including Aurora Cannabis.
Thinking about buying shares in Evgen Pharma? We explain how to do it and compare a range of providers who will give you access to global markets.
Ever wondered how to buy shares in Intuitive Surgical? We explain how and compare a range of providers that can give you access to many brands, including Intuitive Surgical.
Ever wondered how to buy shares in Stryker? We explain how and compare a range of providers that can give you access to many brands, including Stryker.